Literature DB >> 9828115

Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells.

T Yamada1, F Kihara-Negishi, H Yamamoto, M Yamamoto, Y Hashimoto, T Oikawa.   

Abstract

Previously we have shown that overexpression of PU.1, an Ets family transcription factor, in murine erythroleukemia (MEL) cells results in apoptotic cell death in the presence of the differentiation-inducing reagent dimethyl sulfoxide (DMSO). In this study, we examined the dynamics of GATA-1 and NF-E2 hematopoietic transcription factors during the induction of apoptosis, because GATA-1 has been shown to be implicated in survival of erythroid cells. Formation of the GATA-1-DNA complex as judged by EMSA was markedly reduced when apoptosis was induced, although subcellular localization of the GATA-1 protein and expression levels of the GATA-1 mRNA and protein were not changed during the apoptotic process. Complex formation was not reduced when apoptosis was avoided by adding 30% serum in culture medium and when mutant PU.1 proteins with the deletion of the DNA-binding (Ets) or transactivation domain were expressed. Complex formation in nuclear extracts of parental MEL cells was reduced when they were mixed with those of apoptotic cells, suggesting that apoptotic cells may contain a factor(s) preventing GATA-1 from binding to DNA. In contrast to GATA-1, formation of the NF-E2-DNA complex was not changed during the process of apoptosis, although the expression level of the NF-E2 p45 gene was reduced in the process. These results suggest that reduction of the DNA-binding activity of GATA-1 may partly account for PU.1-mediated apoptosis in MEL cells. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9828115     DOI: 10.1006/excr.1998.4251

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Functional cross-antagonism between transcription factors FLI-1 and EKLF.

Authors:  Joëlle Starck; Nathalie Cohet; Colette Gonnet; Sandrine Sarrazin; Zina Doubeikovskaia; Alexandre Doubeikovski; Alexis Verger; Martine Duterque-Coquillaud; François Morle
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

3.  Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins.

Authors:  Ming Ji; Huajie Li; Hyung Chan Suh; Kimberly D Klarmann; Yoshifumi Yokota; Jonathan R Keller
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

4.  PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation.

Authors:  Natasha Rekhtman; Kevin S Choe; Igor Matushansky; Stuart Murray; Tomas Stopka; Arthur I Skoultchi
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

5.  C/EBPalpha determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation.

Authors:  Hyung Chan Suh; John Gooya; Katie Renn; Alan D Friedman; Peter F Johnson; Jonathan R Keller
Journal:  Blood       Date:  2006-02-09       Impact factor: 22.113

Review 6.  Erythroleukemia-historical perspectives and recent advances in diagnosis and management.

Authors:  Prajwal Boddu; Christopher B Benton; Wei Wang; Gautam Borthakur; Joseph D Khoury; Naveen Pemmaraju
Journal:  Blood Rev       Date:  2017-09-18       Impact factor: 8.250

7.  PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells.

Authors:  Takuya Yashiro; Masato Kubo; Hideoki Ogawa; Ko Okumura; Chiharu Nishiyama
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

Review 8.  PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis.

Authors:  Pallavi Gupta; Gangenahalli U Gurudutta; Daman Saluja; Rajendra P Tripathi
Journal:  J Cell Mol Med       Date:  2009-04-06       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.